Pharma Industry
Industry: Email Alert RSS FeedFluticasone cream generic gains tentative approval
Journal of Drugs in Dermatology, Sept-Oct, 2004
The FDA granted Atrix Laboratories tentative approval of the Abbreviated New Drug Application to market fluticasone propionate cream 0.05%. The new generic product is therapeutically bioequivalent to Cutivate, which is marketed by GlaxoSmithKline. The patent for Cutivate cream expired on May 14. 2004.
Most RecentPharma Articles
- Bankers Reveal Top Biotech IPO Contenders; New Filer Ironwood Among Them
- Pfizer Got $160M in Tax Money to Build in Connecticut
- Sanofi's Viehbacher Backs Health Reform; May Change Company's Name
- Viagra Now Available Intravenously
- Genzyme Kidney Drug Failed, Too...What Could Possibly Happen Next?
- More »
COPYRIGHT 2004 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
- How to choose the right insurance carrier for your business
- Real Estate: Prepare your properties to weather what lies ahead
- Technology: Be prepared if part of your global supply chain goes missing
Most Recent Health Articles
Most Recent Health Publications
Most Popular Health Articles
- 50 home remedies that work: these safe, fast, and effective fixes will relieve what ails you - Cover Story
- Detox in 7 days: a detoux diet can help you shed up to 10 pounds and leave you feeling terrific. Our weeklong plan shows you how to lose the weight and keep it off - Cover story
- Treat sinusitis naturally: breath easy and relieve sinus pressure with these remedies - Quick Fixes and Long-Term Solutions
- All about nightshades: explore the hidden hazards of your favorite food with macrobiotic nutritionist Lino Stanchich
- La anemia falciforme - causas y tratamiento
Most Popular Health Publications
Content provided in partnership with
